BNET Industries
Last Fiscal Year Sales:$25.0M
- Public
Dow Jones Description
Nucleic Acid Purification Solutions, Kits & Services
Number of Employees 215
Contact Information
Heron House Oakes Business Park
Crewe Road
Wythenshawe M23 9HZ
(44) 161 946 2200
Peer Companies
NAICS Code In-Vitro Diagnostic Substance Manufacturing: 325413
News & Analysis
Filter by
tepnel life sciences plc. - All News and Analysis
Gen-Probe Completes Acquisition of Tepnel Life Sciences.
SAN DIEGO, April 8 /PRNewswire/ -- -- Transaction Brings Growth Opportunities in Transplant Diagnostics, Genetic Testing and Pharmaceutical Services, Accelerates European Expansion Strategy -- Gen-Probe (Nasdaq: GPRO) announced today that the Company has completed its...
Short route to Sipp profits.
Byline: David Stevenson SIPP DIARY: The carnage has subsided - now it's time to plan for the next five years, with growth and big global themes to the fore My Sipp portfolio is slowly starting to edge ahead again...
Tepnel and SoftGenetics to Offer Rapid Analytics of Congenital Disorders
MANCHESTER, England & STAMFORD, Conn. & STATE COLLEGE, Penn. -- Tepnel Life Sciences PLC (AIM: TED) and SoftGenetics today announced an agreement to market and distribute SoftGenetics GeneMarker([R])genotyping software for use with Tepnel's Elucigene QST*R products for prenatal detection of common chromosome abnormalities. Elucigene QST*R kits are a range of...
TEPNEL LIFE SCIENCES (TED).
Tepnel has reported its first profit - and rising sales should increase that figure over the next few years. The company has two divisions. One is Research Products, which provides outsourcing laboratory services to major drug companies in analysing DNA and proteins. Its top-three customers are...
Tepnel Life Sciences
Tepnel Life Sciences named Abcam the exclusive distributor of its Diaclone diagnostic and research products in Japan, Canada and South America and announced co-exclusive US distribution with Abcam.
Tepnel Life Sciences
UK molecular diagnostics and research products group Tepnel Life Sciences Manchester has begun construction of a pharmaceutical testing facility in Livingston, Scotland, with completion scheduled for Q2 2007.
Tepnel Life Sciences.
Aim. A reorganisation into two distinct operating divisions has helped to improve Tepnel's performance, with strong sales growth in genomic products in particular.
Tepnel Life Sciences.
Aim. The business has been focused into two divisions: Molecular Diagnostics and Research Products and Services. And the Diaclone arm won a significant contract with Germany's Boehringer.
OUT OF OPTIONS?
Remuneration consultants! Get thee to www.tepnel.com and download the 2004 annual report of Tepnel Life Sciences. And when you've got it, check out note 24, where an interesting new incentive method is described. Tepnel's scheme refreshes the parts that other schemes cannot reach,...
Tepnel Life Sciences.
Aim. Tepnel acquired Diaclone in December, increasing its product offering, and withdrew from the less lucrative DNA purification instrument business. It has GBP1.8m cash in the bank.
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes

